Trends in the association between prescribed and non-prescribed use of tranquillisers or sedatives among adolescents in 22 European countries

Abstract

Aims

Tranquillisers and sedatives are valuable medicines with high misuse potential, increasingly used by adolescents without a doctor's prescription. We examined the changing association between lifetime non-prescribed use of tranquillisers or sedatives and their prescribed use in European adolescents in 2003-2011.

Design

Cross-sectional data from 199,231 16-year-old students were collected through anonymous questionnaires administered in schools in 22 European countries participating in the European School Survey Project on Alcohol and Other Drugs (ESPAD) in 2003, 2007 and 2011.

Results

Logistic regression analyses showed a modest increase in lifetime non-prescribed use of tranquillisers or sedatives (adjusted OR [AOR] = 1.08, 95% CI: 1.06-1.11, p < 0.001) and a decrease in prescribed use (AOR = 0.89, 95% CI: 0.87-0.91, p < 0.001) between 2003 and 2011. Adjusting for gender and survey year, any versus no prescribed use increased the odds tenfold for non-prescribed use (AOR = 10.15, 99% CI: 9.60-10.74, p < 0.001). Adjusting also for changes in cannabis use did not affect the strength of the association. Interactions of factors with survey year showed that between 2003 and 2011, there was an increase of 38% in the odds that tranquilliser or sedative misusers had not used these drugs also with a doctor's prescription (AOR = 1.38, 99% CI: 1.28-1.50, p < 0.001).

Conclusion

The waning strength of the association between prescribed and non-prescribed use of tranquillisers or sedatives among adolescents may suggest changes both in the patterns of use and the channels of diversion and access to this class of medication in Europe.

Keywords

tranquillisers sedatives non-prescribed use prescribed use cannabis European adolescents trends ESPAD

References

American Medical Association Council on Science and Public Health (2008). Improving medical practice and patient/family education to reverse the epidemic of nonmedical prescription drug use and addiction. Chicago.

Becker

W. C.

, Fiellin

D. A.

, & Desai

R. A.

(2007). Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: Psychiatric and socio-demographic correlates. Drug and Alcohol Dependence, 90, 280–287.

Boyd

C. J.

, McCabe

S. E.

, Cranford

J. A.

, & Young

(2006). Adolescents' motivations to abuse prescription medications. Pediatrics, 118, 2472–2480.

Boyd

C. J.

, Young

, Grey

, & McCabe

S. E.

(2009). Adolescents' nonmedical use of prescription medications and other problem behaviors. Journal of Adolescent Health, 45, 543–550.

Caplan

J. P.

, Epstein

L. A.

, Quinn

D. K.

, Stevens

J. R.

, & Stern

T. A.

(2007). Neuropsychiatric effects of prescription drug abuse. Neuropsychological Review, 17, 363–380.

Cicero

T. J.

, Lynskey

, Todorov

, Inciardi

J. A.

, & Surratt

H. L.

(2008). Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. Pain, 139, 127–135.

Conway

K. P.

, Compton

, Stinson

F. S.

, & Grant

B. F.

(2006). Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 67, 247–257.

Council of the European Union (2012, December 29). Council Recommendation No. 2012/C 402/01 on the EU Drugs Strategy (2013-20).

Fleary

S. A.

, Heffer

R. W.

, & McKyer

E. L.

(2011). Dispositional, ecological and biological influences on adolescent tranquilizer, Ritalin, and narcotics misuse. J Adolesc, 34, 653–663.

10.

Fotiou

, Kanavou

, Richardson

, Ploumpidis

, & Kokkevi

(in press). Misuse of prescription opioid analgesics among adolescents in Greece: The importance of peer use and past prescriptions. Drugs: Education, Prevention & Policy.

11.

Gobina

, Välimaa

, Tynjälä

, Villberg

, Villerusa

, Iannotti

R.J.

, … Kuntsche

(2011). The medicine use and corresponding subjective health complaints among adolescents, a cross-national survey. Pharmacoepidemiology and Drug Safety, 20, 424–431.

12.

Griffiths

, Evans-Brown

, & Sedefov

(2013). Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age. Addiction, 108, 1700–1703.

13.

Herman-Stahl

M. A.

, Krebs

C. P.

, Kroutil

L. A.

, & Heller

D. C.

(2006). Risk and protective factors for nonmedical use of prescription stimulants and methamphetamine among adolescents. Journal of Adolescent Health, 39, 374–380.

14.

Hibell

, Andersson

, Bjarnason

, Ahlström

, Balakireva

, Kokkevi

, & Morgan

(2004). The 2003 ESPAD report: Substance use among students in 36 countries. Stockholm: CAN & Pompidon Group.

15.

Hibell

, Guttormsson

, Ahlström

, Balakireva

, Bjarnason

, Kokkevi

, & Kraus

(2009). The 2007 ESPAD report: Substance use among students in 36 countries. Stockholm: CAN, EMCDDA & Pompidon Group.

16.

Hibell

, Guttormsson

, Ahlström

, Balakireva

, Bjarnason

, Kokkevi

, & Kraus

(2012). The 2011 ESPAD report: Substance use among students in 36 countries. Stockholm.

17.

International Narcotics Control Board. (2011). Availability of internationally controlled drugs: Ensuring adequate access for medical and scientific purposes (Supplement to the INCB annual report 2010). New York, INCB.

18.

Johnston

, O'Malley

, Bachman

, & Schulenberg

(2012). The rise in teen marijuana use stalls, synthetic marijuana use levels, and use of “bath salts” is very low. Ann Arbor, MI: University of Michigan News Service. Retrieved from: http://www.monitoringthefuture.org.

19.

Johnston

L. D.

, O'Malley

P. M.

, Bachman

J. G.

, & Schulenberg

J. E.

(2013). American teens more cautious about using synthetic drugs. Ann Arbor, MI: University of Michigan News Service. Retrieved from http://www.monitoringthefuture.org.

20.

Johnston

L. D.

, O'Malley

P. M.

, Miech

R. A.

, Bachman

J. G.

, & Schulenberg

J. E.

(2014). Monitoring the Future national results on drug use: 1975-2013: Overview, key findings on adolescent drug use. Ann Arbor: Institute for Social Research, The University of Michigan.

21.

Kokkevi

(2012). Polydrug use by European adolescents: Examining the prevalence of cannabis-related problems among adolescents in 13 European countries. In Hibell

, Guttormsson

, Ahlström

, Balakireva

, Bjarnason

, Kokkevi

, & Kraus

(Eds.), The 2011 ESPAD Report: Substance use among students in 36 countries (pp. 165–170). Stockholm: CAN, EMCDDA, Pompidou Group.

22.

Kokkevi

, Fotiou

, Arapaki

, & Richardson

(2008). Prevalence, patterns, and correlates of tranquilizer and sedative use among European adolescents. Journal of Adolescent Health, 43, 584–592.

23.

McCabe

S. E.

(2005). Correlates of nonmedical use of prescription benzodiazepine anxiolytics: Results from a national survey of U.S. college students. Drug and Alcohol Dependency, 79, 53–62.

24.

McCabe

S. E.

(2008). Misperceptions of non-medical prescription drug use: A web survey of college students. Addictive Behaviors, 33, 713–724.

25.

McCabe

S. E.

, Boyd

C. J.

, & Teter

C. J.

(2009). Subtypes of nonmedical prescription drug misuse. Drug and Alcohol Dependency, 102, 63–70.

26.

McCabe

S. E.

, Boyd

C. J.

, & Young

(2007). Medical and nonmedical use of prescription drugs among secondary school students. Journal of Adolescent Health, 40, 76–83.

27.

McCabe

S. E.

, Teter

C. J.

, & Boyd

C. J.

(2006). Medical use, illicit use and diversion of prescription stimulant medication. Journal of Psychoactive Drugs, 38, 43–56.

28.

McCabe

S. E.

, West

B. T.

, & Boyd

C. J.

(2013). Leftover prescription opioids and nonmedical use among high school seniors: A multi-cohort national study. Journal Adolescent Health, 52, 480–485.

29.

McCabe

S. E.

, West

B. T.

, Morales

, Cranford

J. A.

, & Boyd

C. J.

(2007). Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction, 102, 1920–1930.

30.

McCabe

, West

B. T.

, Teter

C. J.

, & Boyd

C. J.

(2012). Medical and nonmedical use of prescription opioids among high school seniors in the United States. Archives of Pediatrics and Adolescent Medicine, 166, 797–802.

31.

McCabe

S. E.

, West

B. T.

, Teter

C. J.

, & Boyd

C. J.

(2014). Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: Connecting the dots. Addictive Behaviors, 39, 1176–1182.

32.

McLarnon

M. E.

, Darredeau

, Chan

, & Barrett

S. P.

(2013). Motives for the non-prescribed use of psychiatric medications: Relationships with psychopathology, other substance use and patterns of use. Journal of Substance Use (Early Online), 1–8.

33.

Olfson

, Kessler

R. C.

, Berglund

P. A.

, & Lin

(1998). Psychiatric disorder onset and first treatment contact in the United States and Ontario. American Journal of Psychiatry, 155, 1415–1422.

34.

Opaleye

, Noto

, Sanchez

, Amato

, Locatelli

, Gossop

, & Ferri

(2013). Nonprescribed use of tranquilizers or sedatives by adolescents: A Brazilian national survey. BMC Public Health, 13, 499.

35.

Ravens-Sieberer

, Torsheim

, Hetland

, Vollebergh

, Cavallo

, Jericek

, … Erhart

(2009). Subjective health, symptom load and quality of life of children and adolescents in Europe. International Journal of Public Health, 54, 151–159.

36.

Rehm

(2013). Prescription opioids and public health in the European Union. Alice Rap.

37.

Rigg

K. K.

, & Ford

J. A.

(2014). The misuse of benzodiazepines among adolescents: Psychosocial risk factors in a national sample. Drug and Alcohol Dependence. 137, 137–42.

38.

Schepis

T. S.

, & Hakes

J. K.

(2011). Nonmedical prescription use increases the risk for the onset and recurrence of psychopathology: Results from the National Epidemiological Survey on Alcohol and Related Conditions. Addiction, 106, 2146–2155.

39.

Simoni-Wastila

, Yang

H. W.

, & Lawler

(2008). Correlates of prescription drug nonmedical use and problem use by adolescents. Journal of Addiction Medicine, 2, 31–39.

40.

Substance Abuse and Mental Health Services Administration. (2013). The DAWN report: Highlights of the 2011 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. Rockville, MD: Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality.

41.

Sung

H. E.

, Richter

, Vaughan

, Johnson

P. B.

, & Thom

(2005). Nonmedical use of prescription opioids among teenagers in the United States: Trends and correlates. Journal of Adolescent Health, 37, 44–51.

42.

Torsheim

, Ravens-Sieberer

, Hetland

, Välimaa

, Danielson

, & Overpeck

(2006). Cross-national variation of gender differences in adolescent subjective health in Europe and North America. Social Science and Medicine, 62, 815–827.

43.

Wang

P. S.

, Berglund

, Olfson

, Pincus

H. A.

, Wells

K. B.

, & Kessler

R. C.

(2005). Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 603–613.

44.

Young

A. M.

, Glover

, & Havens

J. R.

(2012). Nonmedical use of prescription medications among adolescents in the United States: A systematic review. Journal of Adolescent Health, 51, 6–17.

45.

Zacny

J. P.

, & Lichtor

S. A.

(2008). Nonmedical use of prescription opioids: Motive and ubiquity issues. Journal of Pain, 9, 473–486.